
Medtronic Strengthens Market Position With Hugo Robotics Entry and Diabetes Spinoff
Medtronic gains FDA approval for Hugo robotic surgery system and spins off diabetes division, strengthening market position while reporting 8.7% revenue growth and maintaining 48-year dividend streak.
MDTISRGFDA approvaldividend growth


















